$XBIO 4 SEC Filings

Filed On	Filing
23 Apr 2026	Form 4: Parslow James F, Interim CEO and CFO Received 100,000 shares as a grant or award
05 Jan 2026	Form 4: Vinogradov Alexey Andreevich, Director Granted 2,500 Stock Options
05 Jan 2026	Form 4: Dastoor Firdaus J., Director Granted 2,500 Stock Options
05 Jan 2026	Form 4: Kornberg Roger D., Director Granted 2,500 Stock Options
05 Jan 2026	Form 4: Borisenko Grigory G., Director Granted 2,500 Stock Options
13 Dec 2024	Form 4: Kornberg Roger D., Director Granted 2,500 Stock Options
13 Dec 2024	Form 4: Borisenko Grigory G., Director Granted 2,500 Stock Options
13 Dec 2024	Form 4: Dastoor Firdaus J., Director Granted 2,500 Stock Options
13 Dec 2024	Form 4: Vinogradov Alexey Andreevich, Director Granted 2,500 Stock Options
21 Jun 2024	Form 4: Parslow James F, Interim CEO and CFO Granted 20,000 Stock Options
18 Dec 2023	Form 4: Mizrahy Moshe, Director Granted 2,500 Stock Options
13 Dec 2023	Form 4: Parslow James F, Chief Financial Officer Granted 10,000 Stock Options
13 Dec 2023	Form 4: Lockshin Curtis, Chief Sciencific Officer Granted 10,000 Stock Options
13 Dec 2023	Form 4: Eisenberg Jeffrey F, Director Granted 20,000 Stock Options
08 Dec 2023	Form 4: Kornberg Roger D., Director Granted 2,500 Stock Options
08 Dec 2023	Form 4: Borisenko Grigory G., Director Granted 2,500 Stock Options
08 Dec 2023	Form 4: Dastoor Firdaus J., Director Granted 2,500 Stock Options
08 Dec 2023	Form 4: Callaway James Eric, Director Granted 2,500 Stock Options
08 Dec 2023	Form 4: Vinogradov Alexey Andreevich, Director Granted 2,500 Stock Options
08 Dec 2023	Form 4: Logal Adam, Director Granted 2,500 Stock Options

Comments